Experimental Physiology
	

Celebrating 100 years
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Experimental Physiology 89.4 pp 445-454
DOI: 10.1113/expphysiol.2004.027557
© The Physiological Society 2004
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
89/4/445    most recent
expphysiol.2004.027557v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Hood, S. G.
Right arrow Articles by Woods, R. L.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Hood, S. G.
Right arrow Articles by Woods, R. L.
Related Collections
Right arrow Cardiovascular control

Vagal reflex actions of atrial natriuretic peptide survive physiological but not pathological cardiac hypertrophy in rat

Sally G. Hood and Robyn L. Woods

Howard Florey Institute, University of Melbourne, Victoria 3010, Australia

Atrial natriuretic peptide (ANP) enhances cardiac vagal baroreflexes in normotensive animals. In spontaneously hypertensive rats (SHRs) this effect of ANP was absent. The reflex actions of ANP were preserved if hypertrophy was completely prevented in SHRs. However even a small amount of cardiac hypertrophy, with no hypertension, in SHRs was accompanied by a loss of the reflex bradycardic actions of ANP. In the present study, we investigated whether pathophysiological cardiac hypertrophy, induced by one-kidney, one-clip renovascular hypertension (1K-1C; n= 6), or physiological cardiac hypertrophy induced by chronic spontaneous, wheel-running exercise training (n= 7), similarly prevented vagal reflex actions of ANP. Cardiac baroreceptor-activated bradycardia was measured during rapid ramp increases (~5 s) in blood pressure after bolus doses of methoxamine or vehicle in conscious, chronically instrumented rats during infusions of ANP (50 pmol kg–1 min–1). Compared with uninephrectomised control rats (n= 10), rats with 1K-1C had cardiac hypertrophy (~55% increase in left ventricle:body weight (LV:BW) ratio; P < 0.05) and blunted vagal baroreflex gain (–0.93 ± 0.18 versus–0.50 ± 0.13 beats min–1 mmHg–1; P < 0.05). ANP did not augment baroreflex function in 1K-1C. Compared with their sedentary controls (n= 7), exercise-trained rats with cardiac hypertrophy (~20% increase LV:BW ratio; P < 0.05) also had blunted ramp baroreflex bradycardia (–1.28 ± 0.23 versus–0.57 ± 0.09 beats min–1 mmHg–1; P < 0.05). In contrast, ANP more than doubled baroreflex bradycardia in exercise-trained rats (P < 0.05). The aetiology of cardiac hypertrophy therefore influenced whether ANP retained its vagal baroreflex enhancing properties.

(Received 2 March 2004; accepted after revision 27 April 2004; first published online 6 May 2004)
Corresponding author R. L. Woods: Howard Florey Institute, University of Melbourne, Victoria 3010, Australia. Email: r.woods{at}hfi.unimelb.edu.au







HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2004 by the The Physiological Society.